Current treatment options have improved survival rates but have not provided a cure. Eventually, initial therapies stop ...

This will be Maharashtra’s first public hospital where not just cancer, but also inherited blood disorders in both children ...

ISB 2001, a first-in-class trispecific antibody developed by IGI, showed a 79% response rate in relapsed/refractory multiple ...

In the front row, Dr. Bruno Paiva, with the team from the Multiple Myeloma Group at Cima and the Clínica Universidad de ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing ...

At 38, author Jonathan Gluck was diagnosed with blood cancer and given less than three years to live. He's written a memoir ...

As the authors reported in Radiology Case Reports, the patient had no history of cancer and had no pain, weakness, numbness, ...

CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

GILBERT (AZFamily) — A potential cure for a rare type of blood cancer is currently being used to treat 150 patients at various healthcare centers in the Valley. Details about the medical breakthrough ...

In the two decades since a young father was diagnosed with multiple myeloma, clinical trials and advances in treating his ...